v3.24.3
CONSOLIDATED STATEMENTS OF STOCKHOLDERS’ EQUITY - USD ($)
$ in Thousands
Total
Common Stock Issued
Common Stock in Treasury
Paid-in Capital
Accumulated Other Comprehensive Income (Loss)
Retained Earnings
Beginning balance (in shares) at Dec. 31, 2022   25,000,000        
Beginning balance at Dec. 31, 2022 $ 268,406 $ 250 $ (368,194) $ 326,839 $ (21,187) $ 330,698
Beginning balance (in shares) at Dec. 31, 2022     (12,295,000)      
Increase (Decrease) in Stockholders' Equity [Roll Forward]            
Net income (loss) (61,363)         (61,363)
Currency translation adjustment 1,916       1,916  
Shares issued for employee benefit plan and compensation (in shares)   189,000        
Shares issued for employee benefit plan and compensation 352 $ 2   350    
Purchase of treasury shares (in shares)     (53,000)      
Purchase of treasury shares (812)   $ (812)      
Shares issued to directors (in shares)   8,000        
Shares issued to directors 0          
Employee and director stock-based compensation 2,540     2,540    
Ending balance (in shares) at Mar. 31, 2023   25,197,000        
Ending balance at Mar. 31, 2023 211,039 $ 252 $ (369,006) 329,729 (19,271) 269,335
Ending balance (in shares) at Mar. 31, 2023     (12,348,000)      
Beginning balance (in shares) at Dec. 31, 2022   25,000,000        
Beginning balance at Dec. 31, 2022 268,406 $ 250 $ (368,194) 326,839 (21,187) 330,698
Beginning balance (in shares) at Dec. 31, 2022     (12,295,000)      
Increase (Decrease) in Stockholders' Equity [Roll Forward]            
Net income (loss) (91,136)          
Currency translation adjustment $ (2,702)          
Purchase of treasury shares (in shares) (61,000)          
Purchase of treasury shares $ (888)          
Ending balance (in shares) at Sep. 30, 2023   25,301,000        
Ending balance at Sep. 30, 2023 181,527 $ 253 $ (369,082) 334,683 (23,889) 239,562
Ending balance (in shares) at Sep. 30, 2023     (12,356,000)      
Beginning balance (in shares) at Mar. 31, 2023   25,197,000        
Beginning balance at Mar. 31, 2023 211,039 $ 252 $ (369,006) 329,729 (19,271) 269,335
Beginning balance (in shares) at Mar. 31, 2023     (12,348,000)      
Increase (Decrease) in Stockholders' Equity [Roll Forward]            
Net income (loss) (10,411)         (10,411)
Currency translation adjustment (3,117)       (3,117)  
Shares issued for employee benefit plan and compensation (in shares)   50,000        
Shares issued for employee benefit plan and compensation 373 $ 1   372    
Purchase of treasury shares (in shares)     (5,000)      
Purchase of treasury shares (43)   $ (43)      
Shares issued to directors (in shares)   7,000        
Shares issued to directors 0          
Employee and director stock-based compensation 2,158     2,158    
Ending balance (in shares) at Jun. 30, 2023   25,254,000        
Ending balance at Jun. 30, 2023 199,999 $ 253 $ (369,049) 332,259 (22,388) 258,924
Ending balance (in shares) at Jun. 30, 2023     (12,353,000)      
Increase (Decrease) in Stockholders' Equity [Roll Forward]            
Net income (loss) (19,362)         (19,362)
Currency translation adjustment (1,501)       (1,501)  
Shares issued for employee benefit plan and compensation (in shares)   40,000        
Shares issued for employee benefit plan and compensation 289     289    
Purchase of treasury shares (in shares)     (3,000)      
Purchase of treasury shares (33)   $ (33)      
Shares issued to directors (in shares)   7,000        
Shares issued to directors 0          
Employee and director stock-based compensation 2,135     2,135    
Ending balance (in shares) at Sep. 30, 2023   25,301,000        
Ending balance at Sep. 30, 2023 181,527 $ 253 $ (369,082) 334,683 (23,889) 239,562
Ending balance (in shares) at Sep. 30, 2023     (12,356,000)      
Beginning balance (in shares) at Dec. 31, 2023   25,346,000        
Beginning balance at Dec. 31, 2023 $ 178,920 $ 253 $ (369,973) 336,938 (20,758) 232,460
Beginning balance (in shares) at Dec. 31, 2023 (12,459,845)   (12,460,000)      
Increase (Decrease) in Stockholders' Equity [Roll Forward]            
Net income (loss) $ (8,649)         (8,649)
Currency translation adjustment (1,591)       (1,591)  
Shares issued for employee benefit plan and compensation (in shares)   156,000        
Shares issued for employee benefit plan and compensation 301 $ 2   299    
Purchase of treasury shares (in shares)     (140,000)      
Purchase of treasury shares (1,230)   $ (1,230)      
Shares issued to directors (in shares)   6,000        
Shares issued to directors 0          
Employee and director stock-based compensation 1,904     1,904    
Ending balance (in shares) at Mar. 31, 2024   25,508,000        
Ending balance at Mar. 31, 2024 169,655 $ 255 $ (371,203) 339,141 (22,349) 223,811
Ending balance (in shares) at Mar. 31, 2024     (12,600,000)      
Beginning balance (in shares) at Dec. 31, 2023   25,346,000        
Beginning balance at Dec. 31, 2023 $ 178,920 $ 253 $ (369,973) 336,938 (20,758) 232,460
Beginning balance (in shares) at Dec. 31, 2023 (12,459,845)   (12,460,000)      
Increase (Decrease) in Stockholders' Equity [Roll Forward]            
Net income (loss) $ (19,500)          
Currency translation adjustment $ (2,293)          
Purchase of treasury shares (in shares) (201,000)          
Purchase of treasury shares $ (1,896)          
Ending balance (in shares) at Sep. 30, 2024   25,680,000        
Ending balance at Sep. 30, 2024 $ 161,186 $ 257 $ (371,869) 342,889 (23,051) 212,960
Ending balance (in shares) at Sep. 30, 2024 (12,660,397)   (12,660,000)      
Beginning balance (in shares) at Mar. 31, 2024   25,508,000        
Beginning balance at Mar. 31, 2024 $ 169,655 $ 255 $ (371,203) 339,141 (22,349) 223,811
Beginning balance (in shares) at Mar. 31, 2024     (12,600,000)      
Increase (Decrease) in Stockholders' Equity [Roll Forward]            
Net income (loss) (8,193)         (8,193)
Currency translation adjustment (2,902)       (2,902)  
Shares issued for employee benefit plan and compensation (in shares)   111,000        
Shares issued for employee benefit plan and compensation 362 $ 1   361    
Purchase of treasury shares (in shares)     (55,000)      
Purchase of treasury shares (611)   $ (611)      
Shares issued to directors (in shares)   8,000        
Shares issued to directors 0          
Employee and director stock-based compensation 1,460     1,460    
Ending balance (in shares) at Jun. 30, 2024   25,627,000        
Ending balance at Jun. 30, 2024 159,771 $ 256 $ (371,814) 340,962 (25,251) 215,618
Ending balance (in shares) at Jun. 30, 2024     (12,655,000)      
Increase (Decrease) in Stockholders' Equity [Roll Forward]            
Net income (loss) (2,658)         (2,658)
Currency translation adjustment 2,200       2,200  
Shares issued for employee benefit plan and compensation (in shares)   45,000        
Shares issued for employee benefit plan and compensation 277 $ 1   276    
Purchase of treasury shares (in shares)     (5,000)      
Purchase of treasury shares (55)   $ (55)      
Shares issued to directors (in shares)   8,000        
Shares issued to directors 0          
Employee and director stock-based compensation 1,651     1,651    
Ending balance (in shares) at Sep. 30, 2024   25,680,000        
Ending balance at Sep. 30, 2024 $ 161,186 $ 257 $ (371,869) $ 342,889 $ (23,051) $ 212,960
Ending balance (in shares) at Sep. 30, 2024 (12,660,397)   (12,660,000)